Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03860246 · ClinicalTrials.gov registry record

Atrial Fibrillation Screening in Nursing Homes

A clinical trial of Atrial Fibrillation, sponsored by State University of New York at Buffalo.

Completed
Registry status
245
Enrollment target
1
Study location

NCT03860246 is a study of Atrial Fibrillation that has completed, run by State University of New York at Buffalo. The registered enrollment target is 245 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03860246, a study of Atrial Fibrillation, has completed, sponsored by State University of New York at Buffalo.

COMPLETED
Registry status
245 participants
Enrollment target
1
Study location

Study Summary

This study was designed to screen high risk patients in nursing homes for atrial fibrillation with intermittent electrocardiogram (ECG) recordings using a portable, smartphone-based, mobile ECG recording device (Kardia Mobile, AliveCor, Inc.). The investigators hypothesized that screening patients with 2 or more risk factors for atrial fibrillation would yield a higher incidence of atrial fibrillation compared to prior studies.

Conditions Studied

Atrial Fibrillation

Interventions

  • DIAGNOSTIC_TEST Portable ECG monitor

Study Locations (1)

New York

  • CTRC - Buffalo

Trial Details

FieldValue
Enrollment Target 245 participants
Start Date 2018-02-01
Est. Completion 2018-11-01

Sponsor

State University of New York at Buffalo

243 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03860246

The ClinicalTrials.gov registry entry for NCT03860246 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 245 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (92% lower). The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Portable ECG monitor is the first listed.

NCT03860246 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03860246 about?

NCT03860246 is a clinical study titled "Atrial Fibrillation Screening in Nursing Homes". This study was designed to screen high risk patients in nursing homes for atrial fibrillation with intermittent electrocardiogram (ECG) recordings using a portable, smartphone-based, mobile ECG recording device (Kardia Mobile, AliveCor, Inc.). The investigators hypothesized that screening patients w...

What is the current status of trial NCT03860246?

This trial is currently completed. The enrollment target is 245 participants. The study started on 2018-02-01. Estimated completion is 2018-11-01.

What conditions does trial NCT03860246 study?

This clinical trial studies the following conditions: Atrial Fibrillation.

What interventions are being tested in trial NCT03860246?

The interventions under investigation include: Portable ECG monitor (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03860246?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03860246 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Atrial Fibrillation

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.